Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Molecular and IHC analysis of head and neck carcinomas associated with HPV infection

L. Stanek, K. Glendova, P. Tesarova, R. Gurlich, P. Holeckova, Z. Musil, J. Hrudka, M. Pala, F. Mateicka, M. Chovanec

. 2019 ; 120 (11) : 832-838.

Language English Country Slovakia

Persistent link   https://www.medvik.cz/link/bmc21024789

Head and neck squamous cell carcinomas (HNSCC) are a highly heterogenous disease which can be induced by two main carcinogens – tobacco and/or alcohol, or by HR HPV infection. This work examined 60 paraffin-embedded biopsies of head and neck carcinomas after histological verification. HPV infection, including its specific types in various HNSCC areas, was studied using multiplex qPCR. Expression levels of p16INK4A and p53 were detected by subsequent IHC analysis as being potential diagnostic markers. Based on the assumption that patients with HNSCC could benefit from anti-EGFR therapy (cetuximab), but the predictors are not yet defined, analyses of point mutations of ras genes (Kras, Nras) were carried out using multiplex qPCR and sequence analysis of the Braf gene. All statistical data were processed by Chí-x2 test. HPV infection was detected in 23.34 % of cases with HNSCC, of which 100 % were HPV 16, which is the most frequently infection found in the oropharyngeal region. Using IHC analysis, a positive expression of P16INK4A was detected in 100 % of HPV-positive HNSCC while this expression was discovered to be highly correlated with HPV infection. Furthermore, a correlation between p53 and HPV-negative HNSCC was proved. The mutation incidence was the highest in the Kras gene (codon 12 and codon 146), Nras (codon 12) and Braf. A correlation between tumor location in the oropharyngeal region and Kras mutations was proved. The HPV infection correlated with Kras mutations in case of codon 146 but on the grounds of low amount of output data, these figures could be irrelevant. In one case, c.1808 G>A, protein 603 Arg>Gln mutation was found in the Braf gene but its correlation with head and neck carcinomas has not been described yet (Tab. 2, Fig. 2, Ref. 24).

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21024789
003      
CZ-PrNML
005      
20241201132520.0
007      
cr|cn|
008      
211012s2019 xo ad fs 000 0|eng||
009      
AR
024    0_
$a 10.4149/BLL_2019_138 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xo
100    1_
$a Staněk, Libor $7 xx0141390 $u Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital Prague, Czech Republic $u Department of General Surgery, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic $u St. Elizabeth University of Health and Social Work, Bratislava, Slovakia $u Synlab czech, s.r.o., Prague, Czech Republic
245    10
$a Molecular and IHC analysis of head and neck carcinomas associated with HPV infection / $c L. Stanek, K. Glendova, P. Tesarova, R. Gurlich, P. Holeckova, Z. Musil, J. Hrudka, M. Pala, F. Mateicka, M. Chovanec
504    __
$a Literatura
520    9_
$a Head and neck squamous cell carcinomas (HNSCC) are a highly heterogenous disease which can be induced by two main carcinogens – tobacco and/or alcohol, or by HR HPV infection. This work examined 60 paraffin-embedded biopsies of head and neck carcinomas after histological verification. HPV infection, including its specific types in various HNSCC areas, was studied using multiplex qPCR. Expression levels of p16INK4A and p53 were detected by subsequent IHC analysis as being potential diagnostic markers. Based on the assumption that patients with HNSCC could benefit from anti-EGFR therapy (cetuximab), but the predictors are not yet defined, analyses of point mutations of ras genes (Kras, Nras) were carried out using multiplex qPCR and sequence analysis of the Braf gene. All statistical data were processed by Chí-x2 test. HPV infection was detected in 23.34 % of cases with HNSCC, of which 100 % were HPV 16, which is the most frequently infection found in the oropharyngeal region. Using IHC analysis, a positive expression of P16INK4A was detected in 100 % of HPV-positive HNSCC while this expression was discovered to be highly correlated with HPV infection. Furthermore, a correlation between p53 and HPV-negative HNSCC was proved. The mutation incidence was the highest in the Kras gene (codon 12 and codon 146), Nras (codon 12) and Braf. A correlation between tumor location in the oropharyngeal region and Kras mutations was proved. The HPV infection correlated with Kras mutations in case of codon 146 but on the grounds of low amount of output data, these figures could be irrelevant. In one case, c.1808 G>A, protein 603 Arg>Gln mutation was found in the Braf gene but its correlation with head and neck carcinomas has not been described yet (Tab. 2, Fig. 2, Ref. 24).
650    07
$a lidé $7 D006801 $2 czmesh
650    07
$a nádory hlavy a krku $x genetika $x imunologie $x patologie $7 D006258 $2 czmesh
650    17
$a dlaždicobuněčné karcinomy hlavy a krku $x genetika $x imunologie $7 D000077195 $2 czmesh
650    17
$a infekce papilomavirem $x komplikace $x patologie $7 D030361 $2 czmesh
650    07
$a onkogenní proteiny $x imunologie $x škodlivé účinky $7 D015513 $2 czmesh
650    17
$a imunohistochemie $x metody $7 D007150 $2 czmesh
650    07
$a genetické testování $x metody $7 D005820 $2 czmesh
650    07
$a nádorový supresorový protein p53 $x analýza $x škodlivé účinky $7 D016159 $2 czmesh
650    07
$a inhibitor p16 cyklin-dependentní kinasy $x analýza $x škodlivé účinky $7 D019941 $2 czmesh
650    07
$a nádorové biomarkery $x analýza $7 D014408 $2 czmesh
650    07
$a klinická studie jako téma $x metody $7 D000068456 $2 czmesh
650    07
$a prognóza $7 D011379 $2 czmesh
650    07
$a biopsie $x metody $7 D001706 $2 czmesh
650    07
$a Ras proteiny $x analýza $x genetika $7 D018631 $2 czmesh
700    1_
$a Glendová, Kristýna $7 _AN099990 $u Synlab czech, s.r.o., Prague, Czech Republic
700    1_
$a Tesařová, Petra, $d 1961- $7 xx0102804 $u Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital Prague, Czech Republic
700    1_
$a Gürlich, Robert, $d 1964- $7 xx0000272 $u Department of General Surgery, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Holečková, Petra, $d 1971- $7 xx0092183 $u Institute of Radiation Oncology, Na Bulovce Hospital, Prague, Czech Republic
700    1_
$a Musil, Zdeněk $7 xx0107856 $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hrudka, Jan $7 xx0236562 $u Institute of Pathology, Third Faculty of Medicine, Charles University and University Hospital Královské Vinohrady, Prague, Czech Republic
700    1_
$a Pála, Miloslav $7 xx0088087 $u Institute of Radiation Oncology, Na Bulovce Hospital, Prague, Czech Republic
700    1_
$a Mateička, František $7 xx0241414 $u St. Elizabeth University of Health and Social Work, Bratislava, Slovakia
700    1_
$a Chovanec, Martin, $d 1978- $7 xx0070641 $u Department of Otorhinolaryngology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
773    0_
$t Bratislavské lekárske listy $x 0006-9248 $g Roč. 120, č. 11 (2019), s. 832-838 $w MED00000845
856    41
$u http://www.elis.sk/download_file.php?product_id=6428&session_id=vqcv5omiqd8n4relp2g02i6ia2 $y plný text volně přístupný
910    __
$a ABA008 $b online $c 1067 $y p $z 0
990    __
$a 20211012144111 $b ABA008
991    __
$a 20241130132453 $b ABA008
999    __
$a ok $b bmc $g 1707766 $s 1145295
BAS    __
$a 3 $a 4
BMC    __
$a 2019 $b 120 $c 11 $d 832-838 $i 0006-9248 $m Bratislavské lekárske listy $x MED00000845
LZP    __
$c NLK192 $d 20241130 $a NLK 2021-43/kv

Find record

Citation metrics

Logged in users only

Archiving options